Westpac Banking Corp Tandem Diabetes Care Inc Transaction History

Westpac Banking Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$77.0 - $100.19 $5.53 Million - $7.2 Million	-71,869 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$81.28 - $104.34 $203,200 - $260,850	2,500 Added 3.6%	71,869 $6.34 Million
Q4 2020 Feb 11, 2021	SELL	$86.4 - $121.75 $397,440 - $560,050	-4,600 Reduced 6.22%	69,369 $6.64 Million
Q2 2020 Aug 12, 2020	SELL	$60.05 - $98.92 $663,432 - $1.09 Million	-11,048 Reduced 13.0%	73,969 $7.32 Million
Q1 2020 May 14, 2020	SELL	$47.37 - $90.04 $1.78 Million - $3.38 Million	-37,500 Reduced 30.61%	85,017 $5.47 Million
Q4 2019 Feb 11, 2020	BUY	$53.13 - $71.19 $796,950 - $1.07 Million	15,000 Added 13.95%	122,517 $7.3 Million
Q3 2019 Nov 13, 2019	BUY	$57.11 - $73.3 $936,604 - $1.2 Million	16,400 Added 18.0%	107,517 $6.34 Million
Q2 2019 Aug 01, 2019	SELL	$54.41 - $71.7 $380,870 - $501,900	-7,000 Reduced 7.13%	91,117 $0
Q1 2019 May 14, 2019	SELL	$32.25 - $73.56 $2.32 Million - $5.29 Million	-71,900 Reduced 42.29%	98,117 $0
Q4 2018 Feb 07, 2019	BUY	$28.45 - $40.65 $816,515 - $1.17 Million	28,700 Added 20.31%	170,017 $6.46 Million
Q3 2018 Nov 13, 2018	BUY	$21.39 - $51.17 $3.02 Million - $7.23 Million	141,317 New	141,317 $0

346

70.9M

3.11M

181K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.15B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Westpac Banking Corp with notifications on news.